Registration Questions

Call: 202-684-2034
Email: eventregistration@bisnow.com

Request Speaker Information

Speaker Topics

Tell us a Little More

Event Host

Universities at Shady Grove - Building II

Universities at Shady Grove - Building II

The Universities at Shady Grove (USG) is Maryland’s largest regional higher education center (RHEC), offering upper-level undergraduate and graduate education. USG and its nine University System of Maryland educational partners support and expand pathways to affordable, high-quality public higher education that meet the distinctive needs of the region and are designed to support workforce and economic development for the state of Maryland. Together with its nine partner universities, USG achieves these goals through partnerships and collaborations with academic, business, public sector and community organizations.

Speakers and Panels

Mid-Atlantic's Life Science Innovation

With the newest tools, technology, and designs, how is the Mid-Atlantic keeping up with the latest trends to stay top of the market and lure top tenants?

Martin Rosendale

Martin Rosendale

CEO

Maryland Tech Council

Dr. Amritha Jaishankar

Dr. Amritha Jaishankar

Executive Director

Maryland Stem Cell Research Fund

Richard Bendis

Richard Bendis

CEO

BioHealth Innovation

Abhishek Dhawan

Abhishek Dhawan

Life Sciences Core Market Leader

DPR Construction

Stephen Blair

Stephen Blair

Principal, Science & Technology Practice Director

CannonDesign

Chad House

Chad House

Head of Life Science, Americas

Siemens

Lindsay Ryan
Moderator

Lindsay Ryan

Interim Executive Director

University System of Maryland

Martin Rosendale

CEO

Maryland Tech Council

Martin is the Chief Executive Officer of the Maryland Tech Council, a partner with Newport LLC, and a partner at WMCS Investments. An engineer turned microbiologist and industry leader, Martin is passionate about the human and business value of technology, life sciences, and biotechnology. A five-time CEO and twice company founder, his experience spans public, private and not-for-profit businesses. He has launched, branded, acquired or commercialized more than 10 products and companies. Over 30 years of experience, and a strong drive to achieve and help, enable Martin to work through complexity toward insight and solutions to grow businesses.

Martin has raised equity capital for public and private companies and non-dilutive capital through strategic partnerships. He led a biotherapeutics company through a period of hyper growth taking the company from first sale to $200 million in annual revenue in three years. He worked with the Centers for Medicare and Medicaid Services to establish Medicare reimbursement for a complex product category. He also facilitated the merger of the two largest technology industry organizations in Maryland, forming the Maryland Tech Council and strengthening its industry presence.

Dr. Amritha Jaishankar

Executive Director

Maryland Stem Cell Research Fund

Dr. Amritha Jaishankar serves as the Executive Director, Maryland Stem Cell Research Fund (MSCRF). In this role, Amritha is responsible for oversight of all MSCRF activities, programs, scientific management and oversight of the portfolio, as well as MSCRF business development. She works with stem cell scientists and a variety of key stakeholders to develop a collaborative research program and promote commercialization of stem cell technologies.

MSCRF has invested over $170 million in identifying, supporting, and accelerating cutting-edge research, innovation, clinical trials and commercialization of human stem cell-based technologies in Maryland. Amritha is scientist by training who has devoted her career to developing cures for debilitating and life-threatening conditions of our time and to advancing this field, through various roles in federal, university, and industry settings. She is passionate about using stem cell technologies to accelerate cures for patients in need. Her experience in and outside of the laboratory has made her a proven leader and champion for stem cell research and commercialization.

Since 2016, she has led an Accelerating Cures initiative at MSCRF and has helped create a vibrant and growing stem cell community in the region. She has been recognized for her leadership in life sciences and contributions to the community through numerous awards. Amritha serves on a number of advisory boards and committees in the region

Richard Bendis

CEO

BioHealth Innovation

Mr. Bendis is an entrepreneur, corporate executive, venture capitalist, investment banker, innovation and technology-based economic development leader, international speaker and consultant in the technology and healthcare industries. He currently serves as the founding President and CEO of Innovation America (IA), a national public-private partnership focused on accelerating the growth of innovation economy in America. As one of the most recognized experts in the field of innovation economy, Mr. Bendis has served on numerous distinguished boards and task forces including the White House U.S. Innovation Partnership Advisory Task Force, the Small Business Innovation Research Committee, the National Association of State Venture Funds board; State Science and Technology Institute, and the Ernst and Young Entrepreneurial Institute as a national/regional Judge.

Mr. Bendis has provided global consulting services to over 16 countries and 22 states, several cities and regions, along with international organizations including the United Nations, NATO, UK Trade and Industry, European Commission, French Embassy, the German Marshall Fund, The Canadian Consulate, METI, AKEA, the International Science Parks and Innovation Expert Group and other global entities. Mr. Bendis is a frequent consultant and speaker to 16 International innovation based economic development organizations, as well as over 20 states, regions and cities throughout the U.S. He was voted one of the Top 5 Speakers on innovation economy in 2012.

Stephen Blair

Principal, Science & Technology Practice Director

CannonDesign

Steve has dedicated his career to ensuring science thrives. He leads CannonDesign's award-winning Science & Technology Practice and guides teams in designing projects that supercharge discovery—from buildings designed to develop life-saving cancer treatments to environments that further exploration of space’s outer limits. Steve’s goal on any project is to ensure scientists and researchers across government, health and commercial sectors have optimized, healthy and exhilarating environments where they are able to perform at their best. He partners with top organizations to break barriers, demand more change and take the next steps to achieve their research potential.

Chad House

Head of Life Science, Americas

Siemens

Chad House is the Head of Life Science, Americas for Siemens Industry, Inc. With more than 25 years of industry

experience, he currently leads the development and deployment of go-to-market sales and operational strategies and

the growth of the Siemens Life Science solution/service portfolio. His work includes supporting Siemens branch

offices and implementing standardized processes and best practices to meet the changing needs of life science lab

users and emerging market developments.

Since joining Siemens in 1996, Mr. House has held several positions in sales and operations. He began his career in

engineering and project management, responsible for designing and managing control installation projects. His

career led him into national sales and account management, responsible for managing accounts in a range of

industries, including higher education, healthcare, and research & development laboratories.

Mr. House is an active participant in the life science industry and has been a member of I 2 SL since 2013, currently

serving as a Board of Director. He is a frequent guest speaker and lecturer in the United States for industry-related

events. He holds a Bachelor of Science in HVAC Engineering Technology from Ferris State University.

Lindsay Ryan

Moderator

University System of Maryland

Lindsay Ryan is Interim Executive Director of Economic Development for the University System of

Maryland and coordinates among 12 public institutions throughout Maryland to support innovation,

entrepreneurship, and economic development throughout the System and State. She is the Board

President of the Maryland Business Innovation Association. Previously, she was the Founding Manager

of the business incubator Harbor Launch at IMET and the Chair of the Capital Region Chapter of Women

In Bio. Lindsay began her career in the National Science Foundation’s innovation. She received a B.S. in

Bioengineering from the University of Maryland - College Park and an M.S. from the University of North

Carolina - Chapel Hill studying Marine Microbiology.

The Race for Space: Site-Selection, Conversions and Increase Demand

As Life Science continues to surge, where are investors and developers integrating their new projects?

Michael Darby

Michael Darby

Principal & co-Founder

Monument Realty

Matt Brady

Matt Brady

SVP

Scheer Partners

Jay Brinson

Jay Brinson

VP, Development

Federal Realty

Sandy Young

Sandy Young

Director of Life Sciences

CBRE

CJ Overly

CJ Overly

Senior Project Manager

BXP Life Sciences

Mark Boyce

Mark Boyce

SVP

Transwestern

Martin Togni
Moderator

Martin Togni

Partner

Allen Matkins

Michael Darby

Principal & co-Founder

Monument Realty

Michael J Darby is the principal and founder of Monument Realty, one of the most prolific integrated real estate service firms in the Washington, DC area. Mr. Darby has built Monument into a full-service real estate firm with expertise in Acquisitions, Development, Construction Management, Property Management, Leasing, Investment Sales for Commercial, Residential and Retail property. Through his dynamic leadership and visionary thinking, Mr. Darby has been a driving force in Monument's success for over 23 years and an active member of the Washington region's construction and development industry for nearly 40 years. Mr. Darby served as a senior vice president for Akridge prior to founding Monument. He also directed a number of downtown development projects while at The Carr Company, including such landmark restoration projects as the Willard Hotel and the Southern Railway Building. Today, Monument is transforming neighborhoods throughout the DMV with innovative projects like the new SoNYa district and residential buildings in NoMa, as well as the unprecedented assemblage and preservation project in Chinatown.

Mr. Darby began his career in his native Australia, working with a Melbourne-based general contractor, and holds a degree in Construction Engineering and Business from the University of Melbourne. Mr. Darby has been active in numerous regional real estate organizations over the years and encourages Monument employees to participate in leadership roles in such organizations as the DC Building Industry Association, NAIOP, ULI, Real Estate Group and CREW DC. He is an avid skier, cyclist and kite-surfer and enjoys community outreach. He and his company have been long time supporters of the annual Real Estate Games, a charitable sports competition that supports the Juvenile Diabetes Research Foundation and he was the co-chair for six years.

Matt Brady

SVP

Scheer Partners

Matt Brady has been cultivating his expertise in scientific facilities since 2003. He started his career mentoring under the most pioneering lab real estate minds at Scheer Partners. He has since helped tenants succeed in finding functional space to carry out their groundbreaking scientific processes as well as landlords who had existing labs or were developing labs.

His experiences have established him into one of the foremost authorities on identifying, evaluating, and negotiating lab space in the mid-Atlantic. Matt has a unique understanding that allows him to match scientific processes to real estate solutions.

He has leased and sold over 2,800,000 square feet of scientific space, and worked with a broad spectrum of research, manufacturing, and testing functions including: biotech, pharma, diagnostic, chemical, semiconductor, and agricultural. Matt has advised a range of tenants from start-up companies to full campus headquarters. Additionally, landlords and developers seek his expertise in designing individual labs to ground-up construction as well as guidance to ensure the buildings/spaces will meet the needs of the ever-changing life sciences community.

Jay Brinson

VP, Development

Federal Realty

Jay oversees the strategy and execution of all aspects of development for over two million square feet of real estate, which include some of our most notable assets in the D.C. Metropolitan region, such as Pike & Rose, a nationally recognized mixed-use project in North Bethesda, MD.

Prior to joining the company in 2016, Jay was regional vice president for Brailsford & Dunlavey, where he managed the planning, design, and construction activities for over 40 projects comprising nearly one million square feet of vertical construction valued at over $275 million and the development of long-range capital improvement programs valued at over $8.5 billion. Previously, he held development positions with IBG Partners and Urban Development Associates.

Jay holds an MA in Urban and Regional Planning from Virginia Commonwealth University with a concentration in Economic Development and Community Revitalization, and a BA in Biology from the University of Richmond.

Sandy Young

Director of Life Sciences

CBRE

Sandy Young is a licensed Architectural Engineer, a Certified Construction Manager

and a LEED Accredited Professional in green building and design. She has been

working in the construction field for over 20 years and has completed many projects

in the Life Science industry.

From small to large projects, Ms. Young’s roles have ranged from General Contractor

to Activation Manager to Owner Representative providing her with an excellent

background to navigate all players through the project process. Experience in all

phases including design review, contract management, cost control, budget

management, schedule review, move management and quality control enables Ms.

Young to guide projects to a successful completion.

As Director for CBRE leading their Southeast Region Life Sciences group, Ms. Young

is excited to bring her myriad experience and strong communication skills to create

new spaces that will lead to new health and research discoveries.

CJ Overly

Senior Project Manager

BXP Life Sciences

C.J. Overly is a Senior Project Manager of Development with BXP, formerly Boston Properties, in the Washington, D.C. Region, where he is responsible for the execution of new office, residential, and life science developments. C.J. is currently leading the strategic repositioning, master planning, and project deliveries at the Shady Grove Innovation District, an emerging life science hub with 750K+ SF of future development in Rockville, MD. Prior to Boston Properties, C.J. served in a variety of roles with Trammell Crow Residential, Montgomery County Public Schools (Md.), and JPMorgan Chase. He serves on the board of Maryland Tech Council and is a member of the Urban Land Institute and NAIOP. He received an AA in Business from Montgomery College; a BSBA in Finance from Georgetown University; and, an MBA in Real Estate and Corporate Finance from the University of North Carolina at Chapel Hill.

Mark Boyce

SVP

Transwestern

Mark represents owners and tenants in leasing and acquisitions of office properties throughout the Washington, D.C., metro. He negotiates on behalf of his clients and leads them through leasing negotiations and complex real estate transactions by providing strategic planning, market analysis and financial modeling.

CAREER HIGHLIGHTS

Mark has nearly a decade of experience in commercial real estate. He previously served as a financial and market analyst for Transwestern’s Mid-Atlantic Capital Markets Group, where he was responsible for the due diligence, financial analysis and closing of acquisitions and dispositions of office, retail and industrial properties in the Washington, D.C., area.

Prior to joining Transwestern in 2010, Mark worked at Cushman & Wakefield in Boston with a Medical and Academic Practice Group, where he was responsible for research, analysis and marketing of medical office buildings.

Some of his clients include Boston Properties, Brookfield Properties, Nuveen, Foulger-Pratt, ASB Real Estate, The JBG Smith, M&T Bank, and Ahold USA Inc.

EDUCATION

Mark earned a Bachelor of Science in economics at the University of Wisconsin – Madison.

Martin Togni

Moderator

Allen Matkins

Martin L. Togni is a partner in the San Diego office of Allen Matkins with a practice focusing primarily on Life Sciences, representing a variety of landlords and tenants in the development and leasing of Life Science and Biotech projects. He has successfully completed major leasing transactions totaling more than 40 million square feet in California, the Midwest, and East Coast over the past 25 years, representing some of the nation's leading real estate and end-user companies. Martin also represents a wide variety of clients in the acquisition, disposition, development, financing and ground leasing of shopping centers, industrial projects, office buildings and other commercial and mixed-use projects throughout the country

The Life Science Investment Outlook

The who, what, where and why in the Mid-Atlantic's investment opportunities

Scott Nudelman

Scott Nudelman

Founder

Glenline Investments

Kent Marquis

Kent Marquis

Principal

Stonebridge

Ryan Riel

Ryan Riel

SEVP

EagleBank

Brad Stewart

Brad Stewart

SVP of Business Development

Montgomery County Economic Development Corporation

Adam Schindler

Adam Schindler

Vice Chairman

Colliers

Allissa Kerr
Moderator

Allissa Kerr

Associate

Stroock & Stroock & Lavan

Scott Nudelman

Founder

Glenline Investments

Prior to founding GlenLine in 2019, Scott spent 15 years with Carr Properties, a $3 billion private REIT and one of the Washington, DC region’s most active investors and developers. At Carr, Scott had primary responsibility for acquisitions and dispositions activity in metro Washington and Boston, MA – closing over 40 transactions valued in excess of $2.5 billion while managing many of Carr’s institutional joint venture partnerships. Prior to joining Carr, he executed industrial investments in the Baltimore-Washington corridor at Grange Partners and covered East Coast markets at Archon Group (Goldman Sachs Realty Management).

Scott is a graduate of Dartmouth College and has 24 years of commercial real estate experience. He is a mentor in the Urban Land Institute Washington Mentorship Program and a former board member of the Real Estate Group. Outside of commercial real estate, Scott serves as a trustee of the National Center for Children and Families and in development/strategic growth capacities for Jubilee JumpStart and Miriam’s Kitchen.

Kent Marquis

Principal

Stonebridge

As a Principal with StonebridgeCarras, Kent Marquis focuses on financial strategies relative to acquisitions, asset management, and dispositions. He manages relationships with current and prospective financing partners, directs the underwriting of potential investment properties, manages the firm’s investment assets, and reports on all investments to lenders and investors. He has more than twenty years of experience in the real estate industry with complex joint venture structures spanning a diverse range of property types.

Prior to joining StonebridgeCarras, Mr. Marquis worked in public accounting with Reznick Group in audit/compliance. He holds a Bachelor of Science in Finance and Accounting from Husson University and is a Certified Public Accountant. Mr. Marquis served as co-chair of the District of Columbia Building Industry Association Capital Markets Committee from 2014-2016. He is a member of the Urban Land Institute (ULI) and serves as a mentor in the ULI Mentorship Program.

Ryan Riel

SEVP

EagleBank

Ryan Riel has worked in Commercial Real Estate with EagleBank for more than 20

years and currently oversees the Bank’s $5 billion CRE lending portfolio. Throughout

his tenure, he has worn multiple hats and participated in originating more than $6

billion in real estate transactions of various types across the DC region. Since

February 2025, in addition to CRE Lending, Mr. Riel oversees more than 200

employees across retail banking, small business lending, loan and deposit

operations, and information technology.

Mr. Riel sits on the Board of Directors of the EagleBank Foundation, and on the Board

for George Mason University’s Center for Real Estate Entrepreneurship. He is a

current Trustee for The Children’s Inn at NIH and previously served on the Board of

Directors at the Inn for ten years. He earned a Bachelor’s Degree in Economics from

West Virginia University.

Brad Stewart

SVP of Business Development

Montgomery County Economic Development Corporation

Brad Stewart is a serial biotech entrepreneur working to grow Montgomery County, Maryland’s economy. At the Montgomery County Economic Development Corporation, he leads strategy and innovation and also an expert team of economic development specialists focused on growing a diverse cross-section of businesses—including the life sciences, technology, cybersecurity, defense and hospitality. He chaired Maryland Life Sciences for a decade, the State affiliate of BIO, and is currently Chair of the Maryland Tech Council. Previously, Brad served as Chief Executive Officer of Immunology Partners and Chief Executive Officer of Cylex, Inc., where he executed a turnaround for an early-stage, venture capital-backed company (Roche, Siemens, Canaan Partners).

Adam Schindler

Vice Chairman

Colliers

With commercial real estate experience starting in 2005, Colliers Vice Chairman Adam Schindler specializes in business development and portfolio management, including financial planning, modeling and analysis for corporations, law firms and nonprofit organizations. Schindler’s practice focuses on aligning the needs of occupiers of space with strategic real estate solutions. Adam brings a unique perspective to a vast array of clients with his expertise in the market. His insight keeps him connected and he is able to expand his real estate knowledge not only in the DMV area, but nationally/internationally, as businesses he has worked with grow and look to him for assistance in their real estate needs. Prior to joining Colliers, Adam was a partner at Serten Advisors (acquired by Colliers in 2017).

Retaining and Attracting Life Science & Biotech Talent

The strategies universities and tenants are using to overcome the challenges they are facing with labor shortages

Dr. Annica Wayman

Dr. Annica Wayman

Associate Dean for Shady Grove Affairs

University of Maryland Baltimore County

Dr. Gregory Ball

Dr. Gregory Ball

Vice President for Research

University of Maryland, College Park University of Maryland, Baltimore

Chandra Briggman

Chandra Briggman

President, CEO

Activation Capital

Amanda Cowley

Amanda Cowley

SVP and General Counsel

USP

Helen Montag

Helen Montag

Senior Director, Ecosystem Development

Johns Hopkins Technology Ventures

Janna Sircus
Moderator

Janna Sircus

Human Resources Generalist

Charles River Laboratories

Dr. Annica Wayman

Associate Dean for Shady Grove Affairs

University of Maryland Baltimore County

Annica Wayman is the Associate Dean for Shady Grove Affairs in the College of Natural and

Mathematical Sciences at University of Maryland, Baltimore County (UMBC). In this role, she is primarily

responsible for directing the undergraduate Translational Life Science Technology Bachelor of Science

program and the Master’s of Professional Studies in Biotechnology program. At UMBC, Dr. Wayman is

also part of the STEM BUILD Leadership Team, a NIH-funded program to scale proven interventions to

support undergraduate students from underrepresented groups in science, technology, engineering,

and mathematics (STEM) and their pursuit of biomedical research careers. Her primary responsibility

within STEM BUILD is to chair the Diversity Mentoring External Advisory Team and their development of

a career mentoring program. Immediately prior to her UMBC appointment as Associate Dean, she was

the Division Chief of the Research Partnerships for Development unit in the Global Development Lab at

the United States Agency for International Development (USAID) where her team focused on policies

related to science for development including the Partnerships for Enhanced Engagement in Research

(PEER) program. Dr. Wayman also worked at Becton, Dickinson & Co. (BD) where she served in various

R&D engineering roles ranging from advanced technology development to new product development

for their anesthesia platform. Dr. Wayman received her B.S. in Mechanical Engineering from UMBC and

Ph.D. and M.S. in Mechanical Engineering from the Georgia Institute of Technology. She is on the board

for Harford Community College’s BIOTEC Pathways program and Passion for Learning, a nonprofit

focused on developing technology creation skills of low-income students.

Dr. Gregory Ball

Vice President for Research

University of Maryland, College Park University of Maryland, Baltimore

Gregory F. Ball is the vice president for research for the University of Maryland, College Park and the

University of Maryland, Baltimore, overseeing a joint research enterprise that ranks among the top 10

public institutions in research expenditures, and which garners $1.3 billion in research awards annually.

A noted researcher, Ball maintains a lab in the University of Maryland, College Park Department of

Psychology and participates in the Neuroscience and Cognitive Science program at UMD. He served as

dean of the university’s College of Behavioral and Social Sciences from 2014 to 2022. This is one of the

largest colleges on the College Park campus with 10 departments and multiple centers serving 5,000

undergraduate majors and approximately 900 graduate students. Previously, he was vice dean for

science and research infrastructure in the Krieger School of Arts and Sciences at Johns Hopkins

University and a professor in its Department of Psychological and Brain Sciences for 23 years. At Hopkins

he also had appointments in the School of Medicine and the School of Public Health. Ball has amassed

more than 280 research publications and works in the field of behavioral neuroscience and was elected a

fellow of the American Association for the Advancement of Science in 2014. He is also a fellow of the

American Psychological Association and the American Psychological Society. He has had continuous

NIH funding since the early 1990s. Ball earned a B.A. in psychology from Columbia University and a

Ph.D. in psychobiology from the Institute of Animal Behavior at Rutgers University. He completed post-

doctoral studies at the Rockefeller University in New York.

Chandra Briggman

President, CEO

Activation Capital

Chandra Briggman is President and CEO of Activation Capital, a leading innovation ecosystem development organization providing social, knowledge, and financial capital to tech clusters across the Commonwealth of Virginia.

Before being named the CEO in May 2020, Chandra was Director of Venture Café Foundation located in Cambridge, MA, and was responsible for the strategy and operations of the global network’s flagship Venture Café Cambridge innovation hub. She played a key role in helping expand the revenue and the footprint in New England.

Before her work in ecosystem development in Massachusetts, she held innovation roles with the United States Postal Service in Washington, DC, culminating with her work as the Director of Digital Platforms and the Innovation Lab. Her prior experience comprised leadership roles with multiple startups, including Founder as a serial entrepreneur.

Chandra is an active member of the entrepreneurship and innovation community, including as a guest lecturer, coach/mentor, public speaker, and Chair of the Board for Youth CITIES - a 501(c)(3) non-profit dedicated to youth entrepreneurship.

She earned her Bachelor’s degree in the Humanities from Columbia International University, a Master’s in Marketing from Johns Hopkins University, and an MBA from Massachusetts Institute of Technology.

Amanda Cowley

SVP and General Counsel

USP

Amanda Cowley is General Counsel and Senior Vice President Legal, Strategy and People. She is responsible for ensuring USP is prepared to meet the current and future call of its mission, strengthening the global supply of quality medicines. She oversees USP’s Global strategy, insights, planning and pricing; its Global Legal Affairs, as well as its Legal Standards function, which oversees its unique standard setting role in US law; and its Global Human Resources function.

Amanda is a former Associate Partner at McKinsey & Company, Inc., in Washington, DC. Her work there focused on global health systems and, ultimately, on US health system reform. She oversaw projects with corporations, foundations and governments in Asia, Europe, the Middle East and Africa. Domestically, she spearheaded the development of McKinsey’s portfolio of strategic tools for understanding and responding to the Affordable Care Act (ACA).

In 2010, Amanda left McKinsey to help in the implementation of the ACA. Among other roles, she served as Director, State Health Insurance Marketplaces at the Department of Health and Human Services, where she built and led a new government agency, overseeing the creation, award and administration of a $4+ billion government grant program. Before joining USP, Amanda served as Chief Operating Officer, Account Management for Bridgewater Associates, the world’s largest hedge fund.

Amanda has a JD from Yale Law School, where she served as an Editor on the Yale Law Journal. She is a Harry S Truman Scholar, and graduated magna cum laude with an Economics and Political Science double major from Williams College. She is a member of the DC Bar.

Helen Montag

Senior Director, Ecosystem Development

Johns Hopkins Technology Ventures

Helen Montag is Senior Director for Ecosystem Development at

Johns Hopkins Technology Ventures (JHTV), the

commercialization arm of the University. In this role, she is

responsible for strategic efforts to grow the innovation ecosystem

in Baltimore, leveraging Johns Hopkins’ relationships and

infrastructure to attract and retain talent, companies, real estate

investment and other forms of resources to support researchers

and startups in and around Baltimore. Helen began this role in

January 2021.

Helen has been at Johns Hopkins since 1999 and throughout that

time has been involved in strategic efforts to advance Johns

Hopkins’ innovation agenda. When JHTV was formed in 2014 to

centralize commercialization and entrepreneurship activities,

Helen was charged with the creation of a best-in-class Corporate

Partnerships function to maximize campus research

collaborations with industry partners. She built and led the JHTV

Corporate Partnerships team for eight years, sourcing, shaping

and managing an industry partnerships portfolio that brought over

$120 million in sponsored research funding to Johns Hopkins

researchers. Earlier in her career at Johns Hopkins, she

developed the Johns Hopkins Alliance for Science and

Technology Development program as well as other programs that

train faculty in entrepreneurship. Helen was involved in the early

stages of development for the Johns Hopkins Science &

Technology Park in East Baltimore, which houses the university’s

flagship innovation hub and dozens of startups and

research/manufacturing entities.

Helen received her undergraduate degree from Harvard College,

attended the University of Maryland School of Medicine, received

a Master of Public Health degree at the Johns Hopkins

Bloomberg School of Public Health and completed doctoral work

there as well. Helen has lived in Baltimore since 1987. She was a

2018 member of the Greater Baltimore Committee (GBC)

Leadership Program. She has been on the boards of The Family

Tree, the Roland Park Community Foundation and the Bryn Mawr

School. She spent 12 years on the board of Samuel Ready

Scholarships, a Baltimore based non-profit which provides full

tuition for girls from disadvantaged backgrounds at Baltimore area

private schools, the last two as president.

Janna Sircus

Moderator

Charles River Laboratories

Janna Sircus is a Human Resources Generalist at Charles River Laboratories in Rockville, MD. Amongst other responsibilities, Janna has worked in recruiting new talent, onboarding new employees, and improving the overall employee experience. Prior to its acquisition by Charles River in 2021, Janna worked for Vigene Biosciences, Inc., a premier CDMO providing viral vector-based gene delivery solutions. She has functionally supported (and continues to support) the integration of the two companies with the common goal of growth and expansion in order to drive the safe manufacture of new therapies for the patients who need them. Janna previously worked in a gene discovery laboratory at OriGene Technologies, Inc., where she performed DNA cloning and sequencing to identify gene expression in different types of cancer and the angiogenic response. Janna has a Bachelor’s Degree in Biological Sciences with a specialization in Cell Biology and Molecular Genetics from the University of Maryland, College Park.

Remarks

Dr. Michael Salgaller
Opening Remarks

Dr. Michael Salgaller

Supervisory Specialist, Technology Transfer Center

National Institute of Health

Marc Elrich
Closing Remarks

Marc Elrich

County Executive

Montgomery County

Dr. Michael Salgaller

Opening Remarks

National Institute of Health

Dr. Michael Salgaller leads the Technology Analysis and Marketing Unit (TAMU) within the National Institute of Health’s (NIH’s) Technology Transfer Center, where he leverages over 20 years of business, scientific, and investment experience in various life science sectors to support technology development and commercialization. The TAMU serves in a business development role to foster licensing and collaborative activity between buy-side stakeholders and the NIH. Immediately prior to returning to the NCI, Michael was a Vice President at The Conafay Group, a healthcare-focused government affairs firm in downtown DC, where he led alliance development activities centered on civilian health. He served as President of Biologics Consulting Group, a boutique firm providing professional services focused on regulatory affairs. Michael spent several years on the investment team of an early-stage venture capital firm dedicated to the life sciences. He began his buy-side career as Vice President of R&D for Northwest Biotherapeutics, where he led the development of cancer cell therapies that achieved clinical benefit. He began his career as a Senior Scientist with Dr. Steve Rosenberg at the NCI. He is the author of “Biotechnology Entrepreneurship,” and teaches an entrepreneurship class at NIH. He is on the Board of Canines-N-Kids, a foundation supporting cooperation between researchers in pediatric and veterinary oncology. He has written over 70 scientific/business articles and book chapters. Dr. Salgaller received his PhD in Pathology from The Ohio State University.

Marc Elrich

Closing Remarks

Montgomery County

Marc Elrich was elected as Montgomery County Executive on Nov. 6, 2018. He had previously served three terms (12 years) on the Montgomery County Council as an at-large member, being first elected in 2006. He served as a Councilmember on the Takoma Park City Council from 1987-2006. For 17 years, he was a teacher at Rolling Terrace Elementary School in Takoma Park.

As a County Councilmember, he was the chief sponsor of several landmark pieces of legislation and programs. He led the successful effort to increase the Montgomery County minimum wage in coordination with surrounding jurisdictions to $11.50 an hour and subsequent legislation that will eventually increase the minimum wage to $15 an hour. He was the first elected official to propose building a Bus Rapid Transit (BRT) system throughout the County to address Montgomery's transportation and environmental problems. Ground was broken in Fall 2018 for the first BRT line, which will run along Route 29.

Throughout his political career, he has been a champion of improving tenants' rights and for making developers pay for a greater share of the infrastructure cost to build schools and transportation solutions. He was a leader in the fight to preserve Ten Mile Creek in the Clarksburg area by limiting the proposed development that would have threatened the health of Montgomery County's last best stream which flows into the County's backup water reservoir.

What you'll learn

  • As new markets are embracing the Life Science industry, why are users feeling bullish in investing and developing in the Mid-Atlantic area? How is our region competing with different markets?

  • Strategic Design & Development: How are investors and developers meeting the latest demands when it comes to design and amenities? What is being implemented to ensure purpose-built life science facilities?

  • How are developers and tenants finding more space as demand for facilities continues to rise? Are we seeing more vacant buildings being converted into labs and other biotech facilities to meet the high demand?

  • With the rise in market opportunity, where is the public and private funding coming from for life science real estate?

  • I-270 Corridor Update: What are the newest projects and investments in the development pipeline? What is expected for this life science & biotech corridor in terms of tenants, investments and development in 2022? How are DC & NoVa competing against this corridor and securing their spot in the asset class?

How You'll Do More Business: 

With Montgomery County being one of the top markets in the life science clusters, we're beginning to see an expansion of the asset class throughout the Mid-Atlantic region. According to CBRE, the Washington DC-Baltimore area had over 11 million square feet of available lab space in 2021, and currently has over 700,000 square feet of new lab/R&D construction. What can we expect as we continue through 2022? Hear from the industry's top players at this half-day conference as they discuss the development pipeline, the newest trends and technology, the hottest neighborhoods, the retention of talent, and more.

Who You’ll Meet: Mid-Atlantic's top owners, developers, investors, tenants, architects, GCs and more!

For questions, recommendations, comments, press inquiries, or interest in sponsoring, please email our Mid-Atlantic Event Producer, Katie Telder, at katie.telder@bisnow.com

Venue

Universities at Shady Grove - Building II
9630 Gudelsky Drive
Rockville, MD 20850

Floor: Lobby Level


Parking information: Traville Garage - $3.00 per hour, $15.00 max for the day

Get Directions

Agenda

Time Activity
12:00 PM
1:00 PM
Registration, Networking, and Breakfast
1:00 PM
1:45 PM
Mid-Atlantic's Life Science Innovation

With the newest tools, technology, and designs, how is the Mid-Atlantic keeping up with the latest trends to stay top of the market and lure top tenants?

1:45 PM
2:30 AM
Retaining and Attracting Life Science & Biotech Talent

The strategies universities and tenants are using to overcome the challenges they are facing with labor shortages

2:30 PM
2:45 PM
Networking Break!
2:45 PM
3:30 PM
The Life Science Investment Outlook

The who, what, where and why in the Mid-Atlantic's investment opportunities

3:30 PM
4:15 PM
The Race for Space: Site-Selection, Conversions and Increase Demand

As Life Science continues to surge, where are investors and developers integrating their new projects?

4:15 PM
4:30 PM
Closing Networking

our commitment to your safety

We hosted more than 72,000 attendees live, in-person around the globe in 2021. Our commitment to safety is no different in 2022. Our events follow all local Covid-19 regulations and protocols. In the interest of the safety of all our guests, we recommend taking a rapid or PCR test for proof of negative results before attending any gathering. 

We will update attendees should any regulations be updated before this event is held. We look forward to hosting you soon to do what we do best: network, connect, and engage to do more business.